A new study unveils an innovative strategy to combat Pseudomonas aeruginosa, a major culprit behind food spoilage and ...
The World Health Organization names antimicrobial resistance as one of the most urgent public health threats, but it remains ...
The new funding round targets therapeutics for gram-negative bacterial infections and rapid diagnostics for typhoid fever.
Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...
A new study is exploring the use of Random Antimicrobial Peptide Mixtures (RPMs) as a safe and effective alternative to ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
New Study Highlights Hybrid Nanocomposites as a Dual Solution for Microbial Resistance and Pollution
This study examines silica-based nanocomposites' dual role in antimicrobial and photocatalytic applications, addressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback